A Phase Ia/Ib Study of GH2616 Tablet in Subjects With Advanced Solid Tumors

NCT06329206 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
156
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Suzhou Genhouse Bio Co., Ltd.

Collaborators